For the Inventor, By the Inventor

Enter assignee name

Shanghai, China

Shanghai Yingli Pharmaceutical Co., Ltd

USPTO Granted Patents = 11

CIPO Patents = 1

EPO Patents = 9

Forward Citations = 3

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Zusheng Xu (11 out of 18 patents)

Yangtong Lou (6 out of 8 patents)

Qingrui Sun (4 out of 7 patents)

4. Li Chen (3 out of 114 patents)

5. Tianzhi Wu (2 out of 6 patents)

6. Nong Zhang (2 out of 13 patents)

7. Kun Zeng (2 out of 5 patents)

8. Xiaoli Lei (2 out of 2 patents)

9. Bin Shi (1 out of 6 patents)

10. Jianfeng Wu (1 out of 18 patents)

11. Hongwei Ren (1 out of 1 patent)

12. Jizhi Li (1 out of 1 patent)

13. Su Qian (0 patent)

11 patents: Sort by Forward Citations

1. 11584745 - Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof (2023-02-21),

2. 11505542 - Preparation method for morpholinquinazoline compound and intermediates thereof (2022-11-22),

3. 11466003 - Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof (2022-10-11),

4. 11447490 - Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof (2022-09-20),

5. 11168072 - Crystal form of morpholino quinazoline compound, preparation method therefor and use thereof (2021-11-09),

6. 10100016 - Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof (2018-10-16),

7. 10100015 - Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof (2018-10-16),

8. 9745321 - Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof (2017-08-29),

9. 9738603 - Complex of glucose derivative and proline, crystal, preparation method and use (2017-08-22),

10. 9656996 - Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof (2017-05-23),

11. 9499561 - Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof (2016-11-22),

Shanghai Yingli Pharmaceutical Co., Ltd is a leading pharmaceutical company based in Shanghai, China. With a focus on research, development, and production of innovative drugs, the company aims to improve healthcare globally. Their diverse range of products includes prescription drugs, over-the-counter medicines, and herbal supplements. Yingli Pharmaceutical is committed to ensuring high-quality standards, and their state-of-the-art facilities and experienced team contribute to delivering safe and effective medications. For more information, visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#207 in Shanghai

#2,270 in China

#50,255 in the World

Shanghai, China

Shanghai Yingli Pharmaceutical Co., Ltd

Forward Citations = 3

12 inventors:

Zusheng Xu (11 out of 18 patents)

Yangtong Lou (6 out of 8 patents)

Qingrui Sun (4 out of 7 patents)

4. Li Chen (3 out of 114 patents)

5. Tianzhi Wu (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…